Source comparison
Peptides for Shoulder Injury: Type Comparison
BPC-157 VEGF receptor activation, angiogenesis promotion, NO pathway modulation Rotator cuff tears, tendinitis, ligament sprains 250–500 mcg subcutaneously daily for 4–6 weeks Most studied for acute soft tissue injuries. Strongest evidence for tendon-to-bone h
This comparison does not assign a generated winner or score.
- BPC-157
- VEGF receptor activation, angiogenesis promotion, NO pathway modulation
- Rotator cuff tears, tendinitis, ligament sprains
- 250–500 mcg subcutaneously daily for 4–6 weeks
- Most studied for acute soft tissue injuries. Strongest evidence for tendon-to-bone healing acceleration
- TB-500 (Thymosin Beta-4)
- Actin regulation, fibroblast migration, anti-inflammatory cytokine modulation
- Chronic tendinopathy, labral tears, post-surgical recovery
- 2–2.5 mg twice weekly for 4–8 weeks
- Better suited for chronic injuries and scar tissue remodeling. Reduces fibrosis more effectively than BPC-157
- GHK-Cu (Copper Peptide)
- Collagen synthesis stimulation, MMP modulation, TGF-beta activation
- Superficial muscle strains, minor tendon inflammation
- 1–3 mg daily subcutaneously or topically for 3–4 weeks
- Limited evidence in shoulder-specific injuries. More effective for skin and superficial tissue repair
- IGF-1 LR3
- IGF-1 receptor binding, satellite cell proliferation, protein synthesis
- Muscle atrophy prevention during immobilization
- 20–40 mcg daily post-workout for 4 weeks
- Not a direct injury repair compound. Prevents muscle wasting during recovery phases